Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Immunofoco is a clinical-stage biotech company with a focus on delivering groundbreaking immune cell drugs for patients with solid tumors. The company commenced operations in September 2020, bringing together experts from the industry, academia, business, and medical professions among its founding members. The executive committees at Immunofoco have actively participated in critical activities related to advancing the regulato...
Immunofoco is a clinical-stage biotech company with a focus on delivering groundbreaking immune cell drugs for patients with solid tumors. The company commenced operations in September 2020, bringing together experts from the industry, academia, business, and medical professions among its founding members. The executive committees at Immunofoco have actively participated in critical activities related to advancing the regulatory approval of the first CAR-T drug in China, demonstrating the company's commitment to advancing innovative therapies in the field of immune cell-based treatments.

List your booth number for exhibitions, ask us